Upregulation of BUB1B, CCNB1, CDC7, CDC20, and MCM3 in Tumor Tissues Predicted Worse Overall Survival and Disease-Free Survival in Hepatocellular Carcinoma Patients
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Upregulation of BUB1B, CCNB1, CDC7, CDC20, and MCM3 in Tumor Tissues Predicted Worse Overall Survival and Disease-Free Survival in Hepatocellular Carcinoma Patients
Authors
Keywords
-
Journal
Biomed Research International
Volume 2018, Issue -, Pages 1-8
Publisher
Hindawi Limited
Online
2018-10-01
DOI
10.1155/2018/7897346
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- AASLD guidelines for the treatment of hepatocellular carcinoma
- (2017) Julie K. Heimbach et al. HEPATOLOGY
- Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update
- (2017) Masao Omata et al. Hepatology International
- STAT3-mediated upregulation of lncRNA HOXD-AS1 as a ceRNA facilitates liver cancer metastasis by regulating SOX4
- (2017) Hui Wang et al. Molecular Cancer
- Polymorphisms of CCNB1 Associated With the Clinical Outcomes of Platinum-Based Chemotherapy in Chinese NSCLC Patients
- (2017) Di Liu et al. Journal of Cancer
- Genetic variants of cell cycle pathway genes predict disease-free survival of hepatocellular carcinoma
- (2017) Shun Liu et al. Cancer Medicine
- Future of Hepatocellular Carcinoma Incidence in the United States Forecast Through 2030
- (2016) Jessica L. Petrick et al. JOURNAL OF CLINICAL ONCOLOGY
- Cdc7 is a potent anti-cancer target in pancreatic cancer due to abrogation of the DNA origin activation checkpoint
- (2016) Matthew T. Huggett et al. Oncotarget
- Cdc7 overexpression is an independent prognostic marker and a potential therapeutic target in colorectal cancer
- (2015) Nathaniel Melling et al. Diagnostic Pathology
- Bioinformatics and database resources in hepatology
- (2015) Andreas Teufel JOURNAL OF HEPATOLOGY
- Targeting Cdc20 as a novel cancer therapeutic strategy
- (2015) Lixia Wang et al. PHARMACOLOGY & THERAPEUTICS
- Big Data for Health
- (2015) Javier Andreu-Perez et al. IEEE Journal of Biomedical and Health Informatics
- Cdc20 and securin overexpression predict short-term breast cancer survival
- (2014) H Karra et al. BRITISH JOURNAL OF CANCER
- Chk1-induced CCNB1 overexpression promotes cell proliferation and tumor growth in human colorectal cancer
- (2014) Yifeng Fang et al. CANCER BIOLOGY & THERAPY
- Big Data Bioinformatics
- (2014) Casey S. Greene et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Viral expression and molecular profiling in liver tissue versus microdissected hepatocytes in hepatitis B virus - associated hepatocellular carcinoma
- (2014) Marta Melis et al. Journal of Translational Medicine
- CCNB1 is a prognostic biomarker for ER+ breast cancer
- (2014) Kun Ding et al. MEDICAL HYPOTHESES
- RBM3-Regulated Genes Promote DNA Integrity and Affect Clinical Outcome in Epithelial Ovarian Cancer
- (2014) Õsa Ehlén et al. Translational Oncology
- MCM3 as a Novel Diagnostic Marker in Benign and Malignant Salivary Gland Tumors
- (2013) Zohreh Jaafari Ashkavandi et al. Asian Pacific Journal of Cancer Prevention
- Cdc20: A Potential Novel Therapeutic Target for Cancer Treatment
- (2013) Zhiwei Wang et al. CURRENT PHARMACEUTICAL DESIGN
- High CDC20 expression is associated with poor prognosis in oral squamous cell carcinoma
- (2013) Inês M. B. Moura et al. JOURNAL OF ORAL PATHOLOGY & MEDICINE
- CDC20 overexpression predicts a poor prognosis for patients with colorectal cancer
- (2013) Wen-jing Wu et al. Journal of Translational Medicine
- Clinical significance of cell cycle inhibitors in hepatocellular carcinoma
- (2013) Yasunobu Matsuda et al. Medical Molecular Morphology
- Association Study of Germline Variants in CCNB1 and CDK1 with Breast Cancer Susceptibility, Progression, and Survival among Chinese Han Women
- (2013) Yan Li et al. PLoS One
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
- (2013) J. Gao et al. Science Signaling
- High expression of spindle assembly checkpoint proteins CDC20 and MAD2 is associated with poor prognosis in urothelial bladder cancer
- (2013) Jung-Woo Choi et al. VIRCHOWS ARCHIV
- High MCM3 expression is an independent biomarker of poor prognosis and correlates with reduced RBM3 expression in a prospective cohort of malignant melanoma
- (2012) Björn Nodin et al. Diagnostic Pathology
- Increased CDC20 expression is associated with pancreatic ductal adenocarcinoma differentiation and progression
- (2012) David Z Chang et al. Journal of Hematology & Oncology
- Overexpression of CDC20 predicts poor prognosis in primary non-small cell lung cancer patients
- (2012) Tatsuya Kato et al. JOURNAL OF SURGICAL ONCOLOGY
- High expression of cell division cycle 7 protein correlates with poor prognosis in patients with diffuse large B-cell lymphoma
- (2012) Yun Hou et al. MEDICAL ONCOLOGY
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- Integrative genomic analysis identifies CCNB1 and CDC2 as candidate genes associated with meningioma recurrence
- (2011) Li Bie et al. Cancer Genetics
- High expression of BUBR1 is one of the factors for inducing DNA aneuploidy and progression in gastric cancer
- (2009) Koji Ando et al. CANCER SCIENCE
- The clinicopathological significance of BUBR1 overexpression in hepatocellular carcinoma
- (2009) A-W Liu et al. JOURNAL OF CLINICAL PATHOLOGY
- Mitotic Checkpoint Genes, hsMAD2 and BubR1, in Oesophageal Squamous Cancer Cells and their Association with 5-fluorouracil and Cisplatin-based Radiochemotherapy
- (2008) K. Tanaka et al. CLINICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started